Mariner’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.14M | Buy |
25,823
+524
| +2% | +$43.5K | ﹤0.01% | 1291 |
|
2025
Q1 | $2.05M | Sell |
25,299
-3,475
| -12% | -$282K | ﹤0.01% | 1236 |
|
2024
Q4 | $2.59M | Sell |
28,774
-129
| -0.4% | -$11.6K | ﹤0.01% | 1081 |
|
2024
Q3 | $2.86M | Sell |
28,903
-1,414
| -5% | -$140K | 0.01% | 1018 |
|
2024
Q2 | $2.81M | Sell |
30,317
-261
| -0.9% | -$24.2K | 0.01% | 943 |
|
2024
Q1 | $2.9M | Buy |
30,578
+802
| +3% | +$76.1K | 0.01% | 934 |
|
2023
Q4 | $2.66M | Sell |
29,776
-3,620
| -11% | -$323K | 0.01% | 930 |
|
2023
Q3 | $2.44M | Buy |
33,396
+1,970
| +6% | +$144K | 0.01% | 896 |
|
2023
Q2 | $2.61M | Sell |
31,426
-311
| -1% | -$25.9K | 0.01% | 873 |
|
2023
Q1 | $2.42M | Buy |
31,737
+1,576
| +5% | +$120K | 0.01% | 873 |
|
2022
Q4 | $2.5M | Buy |
30,161
+13,028
| +76% | +$1.08M | 0.01% | 832 |
|
2022
Q3 | $1.36M | Sell |
17,133
-4,391
| -20% | -$348K | 0.01% | 926 |
|
2022
Q2 | $1.6M | Buy |
21,524
+3,697
| +21% | +$275K | 0.01% | 772 |
|
2022
Q1 | $1.6M | Buy |
+17,827
| New | +$1.6M | 0.01% | 790 |
|
2016
Q4 | – | Sell |
-93
| Closed | -$6K | – | 803 |
|
2016
Q3 | $6K | Buy |
+93
| New | +$6K | ﹤0.01% | 756 |
|